William Demant Invest A/S

Overview

William Demant Invest A/S is an evergreen institutional investor based in Denmark, wholly owned by the William Demant Foundation. The company primarily focuses on long-term investments in listed companies, aiming to secure and expand the hearing healthcare company Demant A/S and to donate a share of its net income to charter-defined causes. As of 2024, the market value of its portfolio is approximately DKK 150 billion. The investment strategy of William Demant Invest emphasizes strong underlying market drivers, innovation-driven companies in niche markets with high entry barriers, and large total addressable markets with significant growth potential. The company seeks to increase ownership in its strategic investments, particularly in listed companies with revenues above DKK 250 million, strong profitability, and stable cash flow generation. Notable holdings include Demant A/S, Embla Medical, Vision RT, Vitrolife, CellaVision, Revenio, INVISIO, Jeudan, GN Store Nord, and Pleo. With a global presence, the William Demant Invest family employs more than 35,000 people worldwide. The company's investments span various industries, including healthcare, medical devices, real estate, technology, consumer goods, retail, energy, telecommunications, financial services, pharmaceuticals, biotechnology, media, transportation, logistics, education, hospitality, food and beverage, construction, agriculture, chemicals, and automotive. This diverse portfolio reflects the company's commitment to fostering growth and innovation across multiple sectors.